LMAO .... you're delusional if you think CYP have enough funds to run the USA GVHD trial and keep the lights on at the same time ...... and perhaps if you went to specsavers you would note that I have been a holder since the 12 cent mark so I will comment whenever I feel like it on the CYP threads
Amazing how you (like many on here) had to bring MSB into the conversation ..... not sure what my comments have to do with Mesoblast or with the company's inability to fund the USA FDA GVHD trial with what little they have in the bank (now global in multiple countries so that is surely going to bump up the costs even further) - you know the trial that doesn't 'appear' to have dosed a single patient yet ? Perhaps that is why they intend to open multiple clinics in Turkey ?
I am up circa 65% on my investment in CYP as at today's close so I am happier than many on here - just sayin'
![]()
- Forums
- ASX - By Stock
- CYP
- Ann: Initial Results in First 16 DFU Patients Expected in Q1 2024
CYP
cynata therapeutics limited
Add to My Watchlist
0.00%
!
16.5¢

Ann: Initial Results in First 16 DFU Patients Expected in Q1 2024, page-30
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M |
Open | High | Low | Value | Volume |
16.0¢ | 16.5¢ | 16.0¢ | $10.82K | 65.84K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4450 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 88474 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4450 | 0.165 |
1 | 30000 | 0.160 |
3 | 56451 | 0.155 |
5 | 136673 | 0.150 |
2 | 45937 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 88474 | 2 |
0.175 | 77450 | 2 |
0.180 | 108494 | 4 |
0.185 | 35990 | 1 |
0.190 | 8868 | 1 |
Last trade - 15.32pm 20/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |